Project Name | COVID-19 Vaccine Support Project under the Asia Pacific Vaccine Access Facility | ||||
Project Number | 55012-001 | ||||
Country / Economy | Afghanistan |
||||
Project Status | Active | ||||
Project Type / Modality of Assistance | Grant |
||||
Source of Funding / Amount |
|
||||
Operational Priorities | OP1: Addressing remaining poverty and reducing inequalities OP2: Accelerating progress in gender equality OP7: Fostering regional cooperation and integration |
||||
Sector / Subsector | Health / Disease control of communicable disease |
||||
Gender | Effective gender mainstreaming | ||||
Description | TBD | ||||
Project Rationale and Linkage to Country/Regional Strategy | TBD | ||||
Impact | Vulnerable groups are protected from COVID-19 (National Vaccination Deployment Plan The spread of severe acute respiratory syndrome coronavirus 2 is reduced, and confidence of citizens is restored (ADB's Support to Enhance COVID-19 Vaccine Access) |
Project Outcome | |
---|---|
Description of Outcome | Priority populations vaccinated against COVID-19 |
Progress Toward Outcome | |
Implementation Progress | |
Description of Project Outputs | COVID-19 vaccines procured and delivered to designated points Vaccine program implementation capacity strengthened |
Status of Implementation Progress (Outputs, Activities, and Issues) | |
Geographical Location | Nation-wide |
Safeguard Categories | |
---|---|
Environment | C |
Involuntary Resettlement | C |
Indigenous Peoples | C |
Summary of Environmental and Social Aspects | |
---|---|
Environmental Aspects | |
Involuntary Resettlement | |
Indigenous Peoples | |
Stakeholder Communication, Participation, and Consultation | |
During Project Design | |
During Project Implementation |
Responsible ADB Officer | ADB Disclosure |
Responsible ADB Department | Central and West Asia Department |
Responsible ADB Division | Afghanistan Resident Mission |
Timetable | |
---|---|
Concept Clearance | - |
Fact Finding | 10 Feb 2021 to 15 Mar 2021 |
MRM | 02 Mar 2021 |
Approval | 20 Apr 2021 |
Last Review Mission | - |
Last PDS Update | 21 Apr 2021 |
Milestones | |||||
---|---|---|---|---|---|
Approval | Signing Date | Effectivity Date | Closing | ||
Original | Revised | Actual | |||
20 Apr 2021 | 09 May 2021 | 07 Jun 2021 | 30 Jun 2023 | - | - |
Financing Plan | Grant Utilization | ||||
---|---|---|---|---|---|
Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
Project Cost | 52.00 | Cumulative Contract Awards | |||
ADB | 50.00 | 10 Jul 2022 | 0.00 | 0.00 | 0% |
Counterpart | 2.00 | Cumulative Disbursements | |||
Cofinancing | 0.00 | 10 Jul 2022 | 0.00 | 0.00 | 0% |